Positive airway pressure (PAP) devices are commonly used in hospitals, home settings, and long-term care facilities, by applying continuous, bi-level, intermittent, or expiratory positive airway pressure to non-intubated adult, pediatric, or neonatal patients. They are used on spontaneously breathing patients who require short-term mechanical assistance; however, they are not designed to be life support devices and are not intended to replace basic or advanced mechanical ventilators.
The positive airway pressure devices market report was built to visualize quantitative market trends within anesthesia and respiratory devices therapeutic areas. Moreover, it discusses the effect of COVID -19 on the positive airway pressure devices market for the year 2020 and beyond.
What are the market dynamics in the positive airway pressure devices industry?
Product innovation is a main driver for the market. As patient compliance has been a major factor in the efficacy of PAP treatment, products with improved patient comfort and compliance have been developed. These include more comfortable patient interface systems, and delay timers. These also include bi-level air devices, including variable positive airway pressure (VPAP) systems, which provide different air pressures for inhalation and exhalation; heated humidification systems to make the airflow more comfortable; and auto titration devices that reduce the average pressure delivered during the night.
The other key driver of the market is the shift of care from hospital to home. Non-invasive ventilation at home can reduce healthcare costs associated with the management of patients with severe COPD by greatly increasing the time between hospital readmissions.
What is the regional level outlook of the positive airway pressure devices market?
The key regions in the positive airway pressure devices market are North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.
Positive airway pressure devices market in North America
North America holds the largest share of the market, and the region is also expected to retain its position during the forecast period. In addition, the US holds the largest contribution to the regional market.
Positive airway pressure devices market in Europe
The growth of PAP devices will be stable in the region due to their cost-effectiveness. Reimbursement for PAP services is highly variable across European countries. In addition, prices for PAP devices are also different between and within countries.
Positive airway pressure devices market in Asia Pacific
The market for PAP devices is expected to grow at a stable rate in the APAC region due to the high prevalence and incidence of chronic respiratory diseases in the region. The usage of the devices increases in-home care settings rapidly.
Positive airway pressure devices market in South & Central America
Due to increasing demand, improving healthcare infrastructures, and widening of distribution networks, the market in South & Central America is growing stably. High inflation rates and weakening currencies in some countries have impacted the budgets of the public healthcare systems.
Positive airway pressure devices market in Middle East & Africa
Increasing investments in the healthcare infrastructure, as well as state-of-the-art medical research facilities in the Middle East and Africa, will drive expanded access to the device in the forecast period, along with a growing population, improvements in life expectancy, and increased awareness among both patients and physicians regarding available treatment options.
Positive Airway Pressure Devices Market Analysis by Regions
For more regional insights, download a free report sample
What are the key segments in the positive airway pressure devices market?
The key segments in the positive airway pressure devices market are continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BPAP) devices, and automatic self-adjusting positive airway pressure (APAP) devices.
Continuous Positive Airway Pressure (CPAP) Devices
A continuous positive airway pressure machine is used for the treatment of sleep apnea and in intensive care units as a form of ventilation. Continuous positive airway pressure devices provide gentle and unobstructed breathing by delivering a steady constant pressure of air through a hose that is connected to a nasal mask, nasal pillow, or a full-face mask. The mask must be carefully secured to the face so that no air escapes. This constant supply of air pressure into the throat does not allow air to collapse during inhalation while sleeping.
Bilevel Positive Airway Pressure (BPAP) Devices
Bilevel positive airway pressure is a non-invasive form of therapy for patients suffering from sleep apnea with high-pressure settings or low oxygen levels, which delivers pressurized air through a mask to the patient’s airway and the air keeps the throat muscles from collapsing and reducing obstructions acting as a splint.
Automatic Self-Adjusting Positive Airway Pressure (APAP) Devices
An automatic positive airway pressure device is used for treating obstructive sleep apnea and was mainly developed to improve compliance with CPAP. There will be a constant amount of pressurized air that passes through the hose into the patient’s mask and the pressurized air opens the patient’s airway and eliminates the obstructed airway caused by apneas.
Which are the key companies in the positive airway pressure devices market?
Some of the key companies in the positive airway pressure devices market are Koninklijke Philips NV, ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Breas Medical AB, Teijin Ltd, Koike Medical Co. Ltd, DeVilbiss Healthcare Ltd, and Vyaire Medical Inc.
Positive Airway Pressure Devices Market Analysis by Companies
To know more about key companies, download a free report sample
Market Report Scope
|Key regions||North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa|
|Key segments||Continuous Positive Airway Pressure (CPAP) Devices, Bilevel Positive Airway Pressure (BPAP) Devices, and Automatic Self-Adjusting Positive Airway Pressure (APAP) Devices|
|Key companies||Koninklijke Philips NV, ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Breas Medical AB, Teijin Ltd, Koike Medical Co. Ltd, DeVilbiss Healthcare Ltd, and Vyaire Medical Inc.|
This market model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –
- CMO executives must have a deep understanding of the positive airway pressure devices marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
- Understand the impact of COVID-19 on the positive airway pressure devices market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the positive airway pressure devices market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the positive airway pressure devices market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific positive airway pressure devices market from 2015 to 2030.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Koninklijke Philips NV
Fisher & Paykel Healthcare Corporation Ltd
Vyaire Medical Inc
DeVilbiss Healthcare Ltd
Breas Medical AB
Koike Medical Co Ltd